With a TTM working money circulation of $1.25 billion, Baxter Worldwide Inc. (NYSE:BAX) is included among the many 12 Cash-Rich Stocks to Buy Right Now.
On Might 28, Citi analyst Joanne Wuensch downgraded Baxter Worldwide Inc. (NYSE:BAX) to Promote from Impartial. She lowered the worth goal on the inventory to $17 from $19. In a analysis word, the analyst mentioned the corporate faces a 12 months that’s weighted towards the second half and remains to be looking for a CFO. Citi additionally famous that valuations throughout the broader medical expertise sector are “dipping into worth territory,” which it believes provides traders extra enticing alternatives than Baxter.
On Might 4, Barclays raised its worth advice on Baxter to $27 from $25. It reiterated an Obese score on the shares. The analyst mentioned the corporate exceeded expectations at a time when many traders had anticipated a steerage lower. In a analysis word, Barclays described the outcomes as a “respectable beat and reiterated outlook.”
Baxter Worldwide Inc. (NYSE:BAX) is a worldwide medical expertise firm. Its operations are organized into three segments: Medical Merchandise and Therapies, Healthcare Programs and Applied sciences, and Prescribed drugs.
Whereas we acknowledge the potential of BAX as an funding, we imagine sure AI shares supply better upside potential and carry much less draw back threat. For those who’re searching for a particularly undervalued AI inventory that additionally stands to profit considerably from Trump-era tariffs and the onshoring development, see our free report on the best short-term AI stock.
READ NEXT: 10 Most Profitable Dividend Stocks to Invest In Now and 10 Best Dividend Stocks to Buy According to D. E. Shaw
Disclosure: None. Follow Insider Monkey on Google News.
